COMMUNIQUÉS West-GlobeNewswire

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
17/01/2025
SAN CARLOS, Calif., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal [...]
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
17/01/2025
NOVATO, Calif., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultrarare [...]
Xilio Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
17/01/2025
WALTHAM, Mass., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living [...]
Stryker commences tender offer for all outstanding shares of common stock of Inari Medical, Inc.
17/01/2025
Portage, Michigan, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) today announced that it is commencing, through a wholly owned subsidiary, Eagle 1 Merger Sub, Inc., a cash tender offer to purchase all of the [...]
Disc Medicine Reports Inducement Grant under Nasdaq Listing Rule 5635(C)(4)
17/01/2025
WATERTOWN, Mass., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for [...]
Scorpius Holdings Cancels Planned Reverse Stock Split
17/01/2025
DURHAM, N.C., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract development and manufacturing organization (“CDMO”), today announced [...]
Cannabis Means Business (CMB), New York Global Edition, Opens Registration
17/01/2025
Experience the Premier Trade Show & Conference, June 4-5, For Cannabis Industry Professionals NEW YORK, Jan. 17, 2025 (GLOBE NEWSWIRE) -- via IBN – Cannabis Means Business (CMB), the premier business to business [...]
Mesa Laboratories, Inc. to Announce Third Quarter Results on February 4, 2025
17/01/2025
LAKEWOOD, Colo., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the third quarter of fiscal year 2025 at approximately 8:00 A.M. Eastern [...]
GUERBET : Bilan semestriel du contrat de liquidité
17/01/2025
Bilan semestriel du contrat de liquidité Villepinte, le 17 janvier 2025 Au titre du contrat de liquidité confié par la société GUERBET à BNP Paribas, en date de dénouement du 31 décembre 2024, les moyens suivants [...]
Bionet America, Inc. Launches Super Air Smart ICU
17/01/2025
TUSTIN, Calif., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Bionet America, Inc. today announced the launch of the new Super Air Smart Intensive Care Unit (ICU), providing a spacious, comfortable, and high-tech environment [...]
Abacus Analytics Receives HFMA Peer Review Designation
17/01/2025
CHICAGO, Jan. 17, 2025 (GLOBE NEWSWIRE) -- The Healthcare Financial Management Association (HFMA) recently reviewed Abacus Analytics’ “Usual, Customary and Reasonable Determination Report” methodology using the Peer [...]
Legend Senior Living Announces Expansion in Pittsburgh
17/01/2025
PITTSBURGH, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Legend Senior Living, a national senior living provider operating 12 residences in Pennsylvania today, has assumed management of two senior living communities in the [...]
Enthea to Present at the 2025 Sequire Investor Summit in Puerto Rico
17/01/2025
Boston, MA, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Enthea is proud to announce that it will be presenting at the upcoming Sequire Investor Summit 2025. The 2025 Edition of the Sequire Investor Summit is scheduled for January [...]
Autonomix Medical, Inc. Finalizes Design of ASIC Microchip for Sensing Technology Catheter for Use in Humans, Continuing Progress Toward a U.S. Pivotal Trial in 2025
17/01/2025
Design lock for ASIC microchip follows successful completion of in vivo preclinical and extensive bench testing Manufacturing of ASIC microchip for targeted use in humans has been initiated Company advancing toward [...]
Novo Nordisk A/S: Semaglutide 7.2 mg s.c. achieved 20.7% weight loss in the STEP UP obesity trial, and 18.7% regardless of treatment adherence
17/01/2025
Bagsværd, Denmark, 17 January 2025 – Novo Nordisk today announced headline results from STEP UP, a phase 3b trial in the global STEP programme. STEP UP is a 72-week efficacy and safety trial investigating subcutaneous [...]
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
17/01/2025
BEDFORD, Mass., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”, the “Company”), a biopharmaceutical company committed to redefining the retina experience, today announced that it has [...]
Enovis™ Announces Leadership Change to International Surgical Business
17/01/2025
Wilmington, DE, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Enovis™, a global medical technology innovator headquartered in the United States, announced recently that Davide Visentin will succeed Dr. Benjamin Reinmann as [...]
Immuron Travelan® continued strong sales growth
17/01/2025
Sales Highlights: Global December 2024 Quarter AUD$2.5 million up 70% on prior quarter, up 249% on pcp December 2024 Half Year AUD$4.0 million up 70% on pcp Australia December 2024 Quarter AUD$1.9 million up 83% on [...]
Junshi Biosciences Announces Toripalimab’s Approval in Australia
17/01/2025
SHANGHAI, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, [...]

Pages